CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Fresenius Kabi USA, LLC v. Dr. Reddys Laboratories, Inc.

1:16-cv-00169

Overview

Case Number 1:16-cv-00169
Filing Date 2016-03-17
Status Terminated
Termination Date 2016-06-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Dr. Reddys Laboratories, Ltd. Operating Company

Represented By

2 Attorneys Listed

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Dr. Reddys Laboratories, Inc. Operating Company

Represented By

2 Attorneys Listed

Eve H. Ormerod

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400
Fax: +1 (302) 652-8405

The Brandywine Building, 1000 West Street, Suite 1501

Neal C. Belgam

Smith, Katzenstein, & Jenkins LLP

Tel: +1 (302) 652-8400

1000 West Street, Suite 1501, Wilmington, DE 19801

Plaintiff

Fresenius Kabi USA, LLC Operating Company

Represented By

3 Attorneys Listed

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Ahmed M.T. Riaz

Email: ariaz@schiffhardin.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials 3 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (6 found):
PTAB: 3 U.S. Courts: 3
USPTO PTAB Trial 2017-01-19
IPR2017-00645

Mylan Institutional Inc. v. Fresenius Kabi USA, LLC

U.S. Continuation Sibling (9006289)
Status: Terminated-Settled
USPTO PTAB Trial 2017-01-19
IPR2017-00644

Mylan Institutional Inc. v. Fresenius Kabi USA LLC

U.S. Continuation Sibling (9168239)
Status: Terminated-Settled
USPTO PTAB Trial 2017-01-19
IPR2017-00643

Mylan Institutional Inc. v. Fresenius Kabi USA, LLC

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2016-06-09
1:16-cv-03315

Fresenius Kabi USA, LLC v. Maia Pharmaceuticals, Inc.

Asserted Patent
Status: NJD
U.S. District Court 2016-06-09
1:16-cv-03316

Fresenius Kabi USA, LLC v. Dr. Reddys Laboratories, Inc.

Asserted Patent
Status: NJD
U.S. District Court 2016-04-07
1:16-cv-00237

Fresenius Kabi USA, LLC v. Maia Pharmaceuticals, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9006289
Levothyroxine formulations
Filed: 2012-08-29
Issued: 2015-04-14
Active (5.9 yrs remaining) +35d PTA
Expires: 2032-10-03
US9168238
Levothyroxine formulations
Filed: 2015-03-08
Issued: 2015-10-27
Active (8.3 yrs remaining)
Expires: 2035-03-08
US9168239
Levothyroxine formulations
Filed: 2015-03-13
Issued: 2015-10-27
Active (8.3 yrs remaining)
Expires: 2035-03-13

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

2

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Motion to Transfer Venue (28 U.S.C. Β§ 1404) 2

Key Dispositive Motions & Rulings

Motion to Transfer Venue (28 U.S.C. Β§ 1404) Pending / Under Review
SO ORDERED - re 8 Stipulation and Proposed Order to Avoid Duplicative Briefing on the Motion to Transfer filed by Dr. Reddys Laboratories, Inc., Dr. Reddys Labo...
Entry #11 • 2016-06-08 Document →
Motion to Transfer Venue (28 U.S.C. Β§ 1404) Pending / Under Review
STIPULATION and Proposed Order to Avoid Duplicative Briefing on the Motion to Transfer by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd.. (Ormerod...
Entry #8 • 2016-05-26 Document →

Docket Entries

(23 total)
Pleading / Complaint

COMPLAINT filed against Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1897048.) - filed by Fresenius Kabi USA, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(sec) (Entered: 03/18/2016)

Entry #1 • 2016-03-17
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 03/18/2016)

Entry #2 • 2016-03-17
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/12/2016. Date of Expiration of Patent: SEE ANDA.Thirty Month Stay Deadline: 8/12/2018. (sec) (Entered: 03/18/2016)

Entry #3 • 2016-03-17
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,006,289 B2; US 9,168,238 B2; US 9,168,239 B2. (sec) (Entered: 03/18/2016)

Entry #4 • 2016-03-17
1

Summons Issued with Magistrate Consent Notice attached as to Dr. Reddys Laboratories, Inc. on 3/18/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sec)

Entry #5 • 2016-03-18
1
No Actions

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc